Cancer patients are exposed to potentially harmful radiation during CT (computerized tomography) scans and other X-ray procedures, as well as invasive tests using radioactive isotopes.
That may change if the Korea Communications Commission’s (KCC) plans to back Korean technology aimed at providing a new method of cancer diagnosis succeeds.
The KCC affiliated Electronic and Telecommunications Research Institute (ETRI) is behind experiments using electromagnetic waves in the 3-gigaherz spectrum to detect breast cancer, one of the six cancers that Koreans are most prone.
Clinical trials have been approved by the Korea Food and Drug Administration (KFDA) with a view to commercialization by 2017.
Detectors spot the difference in the electrical response time of healthy cells and cancerous ones using a technique dubbed “micro-wave” tomography.
Read full article on: Korea Times